ReviewJournal of clinical hypertension (Greenwich, Conn.)2026
Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.
Corey Keith Goldman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.